Fig 1.
Patient selection flow chart.
Table 1.
Baseline characteristics among dialysis patients with and without depression.
Fig 2.
Cumulative incidence of (A) death and (B) major cardiovascular events in incident dialysis patients with vs without depression. For the cumulative incidence of major cardiovascular events, Fine-Gray methods were performed accounting for the competing risk of death.
Table 2.
Clinical outcomes associated with depression among incident dialysis patients.
Fig 3.
Cumulative incidence of (A) severe infections and (B) fatal infections in incident dialysis patients with vs without depression. For the cumulative incidences of severe infections, Fine-Gray methods were performed accounting for the competing risk of death.
Fig 4.
Risks of single infection events associated with clinical depression.
Footnote: Subdistribution hazard Model: Adjusted for comorbid disorders (diabetes mellitus, hypertension, hyperlipidaemia, coronary artery disease, cerebrovascular disease, autoimmune disease, malignancy, alcohol dependence, psychotic disorder, anxiety disorder, sleep disorder), medications (antiplatelets/warfarin, anti-hypertensive drugs, statins, oral antidiabetic agents, insulin, antipsychotic agents, benzodiazepines, hypnotics), and competing risk of mortality *p<0.05, **p<0.01, ***p<0.001.